Keyphrases
Bone Loss
100%
Glucagon-like
100%
Receptor Agonist
100%
Agonist Treatment
100%
A1 Receptor
100%
Weight Loss
100%
Bone Formation
100%
Obese Women
100%
Bone Mineral Content
57%
Liraglutide
57%
Weight Maintenance
57%
Bone Turnover Markers
57%
Low-calorie Diet
42%
Leg Bones
42%
Procollagen Type 1 N-terminal Propeptide (P1NP)
42%
CTX-1
28%
Type I Procollagen
14%
Bone Turnover
14%
C-terminal Telopeptide of Type I Collagen
14%
Collagen
14%
Diet-induced
14%
Weight Gain
14%
Content Loss
14%
Research Hospital
14%
Weight Reduction
14%
Hospital Clinic
14%
Confidence Interval
14%
Healthy Obese
14%
Maintenance Phase
14%
Randomized Controlled Study
14%
Body Mass Index
14%
Medicine and Dentistry
Osteolysis
100%
Ossification
100%
Glucagon Like Peptide 1
100%
Glucagon-Like Peptide-1 Agonist
100%
Liraglutide
80%
Bone Mineral
80%
Low Calorie Diet
60%
Leg Bone
60%
Arm
60%
Pelvis
40%
Procollagen
20%
C-Terminal Telopeptide
20%
Bone Turnover
20%
Collagen Type 1
20%
Amino Terminal Sequence
20%
Body Mass Index
20%
Bone Mass
20%
Outpatient
20%
Biochemistry, Genetics and Molecular Biology
Glucagon-Like Peptide 1 Receptor
100%
Osteolysis
100%
Receptor Agonists
100%
Glucagon-Like Peptide-1
100%
Ossification
100%
Liraglutide
80%
Calorie
60%
Bone Mass
20%
C-Terminal Telopeptide
20%
N-Terminus
20%
Bone Turnover
20%
Body Mass
20%
Type I Collagen
20%
Immunology and Microbiology
Glucagon-Like Peptide-1
100%
Ossification
100%
Osteolysis
100%
Agonist
100%
Bone Mineral
57%
Calorie
42%
Arm
42%
Pelvis
28%
Body Mass
14%
Carboxy Terminal Sequence
14%
Amino Terminal Sequence
14%
Bone Turnover
14%
Bone Mass
14%
Pharmacology, Toxicology and Pharmaceutical Science
Glucagon Like Peptide 1 Receptor Agonist
100%
Glucagon-Like Peptide-1
100%
Liraglutide
80%
Collagen Type 1
20%
Telopeptide
20%
Procollagen
20%